Enveric Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary
I'm PortAI, I can summarize articles.
Enveric Biosciences IncQ) reported a quarterly adjusted loss of $4.80 per share for the quarter ended December 31, significantly higher than last year's loss of $22.05 per share. The company reported zero revenue and a total loss of $3.16 million. Shares fell by 70.2% this quarter. Analysts' earnings estimates had risen by 96.2% in the last three months, with a current average rating of "buy". The median 12-month price target is $54.80.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments